GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Trulieve Cannabis Corp (OTCPK:TCNNF) » Definitions » EBITDA Margin %

TCNNF (Trulieve Cannabis) EBITDA Margin % : 17.32% (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Trulieve Cannabis EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Trulieve Cannabis's EBITDA for the three months ended in Sep. 2024 was $49 Mil. Trulieve Cannabis's Revenue for the three months ended in Sep. 2024 was $284 Mil. Therefore, Trulieve Cannabis's EBITDA margin for the quarter that ended in Sep. 2024 was 17.32%.


Trulieve Cannabis EBITDA Margin % Historical Data

The historical data trend for Trulieve Cannabis's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trulieve Cannabis EBITDA Margin % Chart

Trulieve Cannabis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 50.84 39.86 30.43 19.68 -1.95

Trulieve Cannabis Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.54 25.66 30.39 31.67 17.32

Competitive Comparison of Trulieve Cannabis's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Trulieve Cannabis's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Trulieve Cannabis's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Trulieve Cannabis's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Trulieve Cannabis's EBITDA Margin % falls into.



Trulieve Cannabis EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Trulieve Cannabis's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-21.978/1129.193
=-1.95 %

Trulieve Cannabis's EBITDA Margin % for the quarter that ended in Sep. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=49.237/284.284
=17.32 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Trulieve Cannabis  (OTCPK:TCNNF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Trulieve Cannabis EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Trulieve Cannabis's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Trulieve Cannabis Business Description

Traded in Other Exchanges
Address
6749 Ben Bostic Road, Quincy, FL, USA, 32351
Trulieve Cannabis Corp is a vertically integrated seed to sale and fully licensed medical marijuana company. It is mainly engaged in the cultivation, possession, use, sale, and distribution of medical cannabis.
Executives
Timothy E Mullany officer: Chief Financial Officer 3551 PLANO PARKWAY, THE COLONY TX 75056
Ryan Blust officer: Chief Financial Officer 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Joy Malivuk officer: Chief Accounting Officer 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Peter Healy director C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Rebecca L. Young officer: Chief Accounting Officer C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Kim A. Rivers director, 10 percent owner, officer: Chief Executive Officer C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Thomas L Millner director, 10 percent owner
Thad Beshears director, 10 percent owner C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Kyle Landrum officer: Chief Production Officer C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Timothy Morey officer: Chief Sales Officer C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Eric Powers officer: GC and Corporate Secretary C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Susan Thronson director C/O ANGIE'S LIST, INC., 1030 E. WASHINGTON STREET, INDIANPOLIS IN 46202
Alex D'amico officer: Chief Financial Officer 10 EAST PASSAIC AVENUE, UNIT C-2, NUTLEY NJ 07110
Giannella Alvarez director C/O DOMTAR CORPORATION, 234 KINGSLEY PARK DRIVE, FORT MILL SC 29715
Jane C Morreau director